JP2009530282A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530282A5
JP2009530282A5 JP2009500435A JP2009500435A JP2009530282A5 JP 2009530282 A5 JP2009530282 A5 JP 2009530282A5 JP 2009500435 A JP2009500435 A JP 2009500435A JP 2009500435 A JP2009500435 A JP 2009500435A JP 2009530282 A5 JP2009530282 A5 JP 2009530282A5
Authority
JP
Japan
Prior art keywords
carbon
asterisk
enantiomer
indicated
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500435A
Other languages
English (en)
Other versions
JP2009530282A (ja
JP5313124B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/006320 external-priority patent/WO2007109023A1/en
Publication of JP2009530282A publication Critical patent/JP2009530282A/ja
Publication of JP2009530282A5 publication Critical patent/JP2009530282A5/ja
Application granted granted Critical
Publication of JP5313124B2 publication Critical patent/JP5313124B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

発明の詳細な説明
Ｉ．定義
本明細書で用いる用語“５５％以上のエナンチオマー過剰率（ｅｅ）”は、一方のエナンチオマーが、化合物中他方よりも５５％またはそれ以上存在することを意味する。該エナンチオマーは、式１：
Figure 2009530282
中アミノ基が結合する炭素中心（アスタリスクで示される）か、または式１中ヒドロキシル基が結合する炭素中心（これもアスタリスクで示される）か、または両方の炭素中心の結果であり得る。例えば、カルボニル基から離れる順に番号付けされた化合物は、これらの２個の炭素中心において（２Ｓ，３Ｓ）、（２Ｓ，３Ｒ）、（２Ｒ，３Ｒ）または（２Ｒ，３Ｓ）であり得る。
実施例１４：（２Ｓ，３Ｓ）−３−アミノ−Ｎ−シクロプロピル−２−ヒドロキシヘキサンアミド塩酸塩の製造
Figure 2009530282

JP2009500435A 2006-03-16 2007-03-14 立体的化合物を製造するための方法および中間体 Expired - Fee Related JP5313124B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78297606P 2006-03-16 2006-03-16
US60/782,976 2006-03-16
US84477106P 2006-09-15 2006-09-15
US60/844,771 2006-09-15
PCT/US2007/006320 WO2007109023A1 (en) 2006-03-16 2007-03-14 Processes and intermediates for preparing steric compounds

Publications (3)

Publication Number Publication Date
JP2009530282A JP2009530282A (ja) 2009-08-27
JP2009530282A5 true JP2009530282A5 (ja) 2010-05-06
JP5313124B2 JP5313124B2 (ja) 2013-10-09

Family

ID=38222510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500435A Expired - Fee Related JP5313124B2 (ja) 2006-03-16 2007-03-14 立体的化合物を製造するための方法および中間体

Country Status (15)

Country Link
US (3) US20070244334A1 (ja)
EP (3) EP2407448A3 (ja)
JP (1) JP5313124B2 (ja)
KR (1) KR101398259B1 (ja)
AR (1) AR059916A1 (ja)
AU (1) AU2007227580A1 (ja)
BR (1) BRPI0709568A2 (ja)
CA (1) CA2646123A1 (ja)
HK (1) HK1132988A1 (ja)
MX (1) MX2008011869A (ja)
NZ (1) NZ571281A (ja)
RU (1) RU2013105768A (ja)
SG (1) SG170729A1 (ja)
TW (2) TWI466851B (ja)
WO (1) WO2007109023A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL194025B1 (pl) 1996-10-18 2007-04-30 Vertex Pharma Inhibitory proteaz serynowych, a zwłaszcza proteazy wirusa NS3 zapalenia wątroby C, kompozycja farmaceutyczna i zastosowanie inhibitorów proteaz serynowych
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
MY148123A (en) 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
EP1991229A2 (en) 2006-02-27 2008-11-19 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
CA2646229A1 (en) 2006-03-16 2007-09-27 Vertex Pharmaceuticals Incorporated Deuterated hepatitis c protease inhibitors
WO2007138928A1 (ja) * 2006-05-26 2007-12-06 Kaneka Corporation 光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
DE102006059317A1 (de) * 2006-07-04 2008-01-10 Evonik Degussa Gmbh Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden
DE102006042147A1 (de) * 2006-09-06 2008-03-27 Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik Hydrochloride von 3-Amino-2-hydroxycarbonsäureamiden
AP2009004960A0 (en) 2007-02-27 2009-08-31 Vertex Pharma Co-crystals and pharmaceutical compositions comprising the same
CA2679426A1 (en) 2007-02-27 2008-09-04 Luc Farmer Inhibitors of serine proteases
EP2436682A1 (en) 2007-08-30 2012-04-04 Vertex Pharmceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
WO2013186248A1 (en) 2012-06-13 2013-12-19 Janssen Pharmaceutica Nv A method for the preparation of 3-amino-n-cyclopropyl-2-hydroxyl-hexanamide
CN103508918B (zh) * 2012-06-18 2015-09-09 上海医药工业研究院 带有环丁基的α-羟基β-氨基酯类化合物及其制备方法
EP2864321A1 (en) 2012-06-20 2015-04-29 Sandoz AG SYNTHESIS OF TELAPREVIR AND BOCEPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF INCLUDING ß-AMINO ACIDS PREPARED VIA MUKAIYAMA ALDOL ADDITION
WO2013189978A1 (en) 2012-06-20 2013-12-27 Sandoz Ag PROCESS FOR PREPARING ß-AMINO ACID DERIVATIVES AND USE OF SAID PROCESS FOR PREPARING TELAPREVIR
WO2014033667A1 (en) 2012-08-30 2014-03-06 Ranbaxy Laboratories Limited Process for the preparation of telaprevir
WO2014083582A2 (en) * 2012-11-29 2014-06-05 Msn Laboratories Limited Novel process for the preparation of (1s,3ar,6as)-2-[(2s)-2-({(2s)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-n-[(3s)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c] pyrrole-1-carboxamide and its intermediates
WO2014203224A1 (en) 2013-06-21 2014-12-24 Ranbaxy Laboratories Limited Process for the preparation of telaprevir and its intermediates
WO2014203208A1 (en) 2013-06-21 2014-12-24 Ranbaxy Laboratories Limited Process for the preparation of telaprevir and intermediates thereof
CN104926831A (zh) * 2014-03-20 2015-09-23 上海医药工业研究院 合成特拉匹韦的中间体及其制备方法
CN110577506B (zh) * 2018-06-07 2023-04-07 中国科学院上海有机化学研究所 (﹣)-三尖杉碱的酯类衍生物的合成方法及其中间体

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US711530A (en) 1902-07-30 1902-10-21 Kempshall Mfg Co Playing-ball.
US782976A (en) 1904-05-21 1905-02-21 Patrick Thomas Lyons Water-heater.
US782778A (en) 1904-06-04 1905-02-14 Gas And Electric Protective Company Emergency fire apparatus for buildings.
US844771A (en) 1906-09-07 1907-02-19 Horace M Bellows Aerial navigation.
DE2136067C3 (de) * 1970-08-03 1980-09-11 Merck & Co., Inc., Rahway, N.J. (V.St.A.) 3-Fluor-D-alanin, 3-Fluor-D-alanin-2-d, deren Salze und diese Verbindungen enthaltende Arzneimittel
JPS54163544A (en) * 1978-06-09 1979-12-26 Nippon Kayaku Kk Dllthreo and dllerythroo 33aminoo22hydroxyy44 phenylbutanoic acid amide and method
JPS5557547A (en) * 1978-10-25 1980-04-28 Nippon Kayaku Co Ltd Dl-threo- and dl-erythro-3-amino-2-hydroxy-5- methylhexanoic acid amides and their preparation
JP3046369B2 (ja) * 1990-03-15 2000-05-29 エーザイ株式会社 光学異性体分離剤
JP3863230B2 (ja) 1996-08-16 2006-12-27 株式会社カネカ β−アミノ−α−ヒドロキシ酸誘導体の製造方法
DE69725023T2 (de) 1996-10-08 2004-08-05 Colorado State University Research Foundation, Fort Collins Katalytische asymmetrische epoxidierung
EP0978508B1 (de) * 1998-08-05 2005-12-14 DSM IP Assets B.V. Herstellung von 4,4'-Diketo-carotinoiden
US6025516A (en) * 1998-10-14 2000-02-15 Chiragene, Inc. Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
WO2000055113A1 (en) 1999-03-12 2000-09-21 Ajinomoto Co.,Inc. PROCESS FOR THE PREPARATION OF α-AMINOKETONE DERIVATIVES
JP4666440B2 (ja) * 2000-06-30 2011-04-06 生化学工業株式会社 アミノアルコール誘導体
JP4421141B2 (ja) * 2000-06-30 2010-02-24 生化学工業株式会社 アジド誘導体
EP2289888A3 (en) 2000-06-30 2011-07-13 Seikagaku Corporation Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
CA2450545A1 (en) * 2001-07-03 2003-01-16 Altana Pharma Ag Process for the production of 3-phenylisoserine
JP2003055389A (ja) 2001-08-09 2003-02-26 Univ Tokyo 錯体及びそれを用いたエポキシドの製法
JP3924613B2 (ja) * 2002-11-06 2007-06-06 国立大学法人 東京大学 α，β−エポキシアミドの製法
JP4239622B2 (ja) * 2003-03-11 2009-03-18 東ソー株式会社 不斉エポキシ触媒及びそれを用いた光学活性エポキシドの製造方法
ES2346233T3 (es) 2004-02-27 2010-10-13 Schering Corporation Compuestos de azufre como inhibidores de serina proteasa ns3 del virus de la hepatitis c.
CA2574625A1 (en) 2004-07-23 2006-01-26 Thijs Kuilman Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester
US7441786B2 (en) * 2005-03-07 2008-10-28 Stryker Corporation Convertible low profile roller and support base
WO2007002013A2 (en) * 2005-06-20 2007-01-04 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
SI2194043T1 (sl) * 2005-08-19 2014-04-30 Vertex Pharmaceuticals Incorporated Postopki
JP4851804B2 (ja) 2006-02-13 2012-01-11 株式会社日立ハイテクノロジーズ 集束イオンビーム加工観察装置、集束イオンビーム加工観察システム及び加工観察方法
JP2009132621A (ja) * 2006-03-13 2009-06-18 Ajinomoto Co Inc シクロプロピルアミド化合物の製造方法
DE102006059317A1 (de) * 2006-07-04 2008-01-10 Evonik Degussa Gmbh Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden

Similar Documents

Publication Publication Date Title
JP2009530282A5 (ja)
JP2010501534A5 (ja)
JP2008525553A5 (ja)
JP2006526031A5 (ja)
EP2407448A3 (en) Processes and intermediates for preparing steric compounds
CY1110075T1 (el) Παρασκευη(2r,3r)-3-(3-μεθοξυφαινυλ)-ν,ν,2-τριμεθυλοπενταναμινης
JP2010536766A5 (ja)
JP2009535462A5 (ja)
JP2017214410A5 (ja)
JP2018531941A5 (ja)
JP2009004351A5 (ja)
JP2007522220A5 (ja)
EP2692827A3 (en) Liquid-crystalline medium
ATE515491T1 (de) Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol
JP2011518833A5 (ja)
WO2010000372A3 (en) New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
MA51204B1 (fr) Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique
JP2009545527A5 (ja)
JP2014500861A5 (ja)
JP2008546809A5 (ja)
EA201490756A1 (ru) Разагилина цитрамид
EP3112358A3 (en) 3,6-disubstituted xanthylium salts
JP2010507589A5 (ja) Ｃｂ１受容体モジュレーターとしての１，５−ジフェニル−３−ピリジニルアミノ−１，５−ジヒドロピロリジン−２−オン
EP2759540A3 (en) Beta-3 receptor ligands and their use in therapy
JP2012511558A5 (ja)